Altimmune Inc [NASDAQ: ALT] jumped around 2819992.81 points on Wednesday, while shares priced at $2820000.0 at the close of the session, up 7.23%.
Altimmune Inc stock is now 20.28% up from its year-to-date (YTD) trading value. ALT Stock saw the intraday high of $7.73 and lowest of $6.89 per share. The company’s 52-week high price is 11.16, which means current price is +117.00% above from all time high which was touched on 01/08/25.
Compared to the average trading volume of 2.82M shares, ALT reached a trading volume of 5241976 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Altimmune Inc [ALT]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ALT shares is $22.38 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ALT stock is a recommendation set at 1.22. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
William Blair have made an estimate for Altimmune Inc shares, keeping their opinion on the stock as Mkt Perform, with their previous recommendation back on February 28, 2025. While these analysts kept the previous recommendation, Stifel raised their target price to Buy. The new note on the price target was released on January 08, 2025, representing the official price target for Altimmune Inc stock. Previously, the target price had yet another raise to $26, while UBS analysts kept a Buy rating on ALT stock.
The Price to Book ratio for the last quarter was 4.22, with the Price to Cash per share for the same quarter was set at 1.85.
How has ALT stock performed recently?
Altimmune Inc [ALT] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 11.90. With this latest performance, ALT shares gained by 35.03% in over the last four-week period, additionally sinking by -5.75% over the last 6 months – not to mention a rise of 6.93% in the past year of trading.
Altimmune Inc [ALT]: Deeper insight into the fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Altimmune Inc [ALT] shares currently have an operating margin of -490965.00% and a Gross Margin at -700.00%. Altimmune Inc’s Net Margin is presently recorded at -451200.00%.
Return on Equity for this stock declined to -52.22%, with Return on Assets sitting at -52.22%.
Earnings analysis for Altimmune Inc [ALT]
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for ALT. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Altimmune Inc go to 0.61%.
Insider trade positions for Altimmune Inc [ALT]
There are presently around $47.87%, or 48.23% of ALT stock, in the hands of institutional investors. The top three institutional holders of ALT stocks are: BLACKROCK INC. with ownership of 5.32 million shares, which is approximately 7.5025%. VANGUARD GROUP INC, holding 4.91 million shares of the stock with an approximate value of $$32.63 million in ALT stocks shares; and VANGUARD GROUP INC, currently with $$26.0 million in ALT stock with ownership which is approximately 5.5119%.
